Selenium levels in colorectal cancer : A systematic review and meta-analysis of serum, plasma, and colorectal specimens
Copyright © 2024 Elsevier GmbH. All rights reserved..
BACKGROUND: Colorectal cancer (CRC) is a growing public health problem. Several clinical studies have shown a potentially protective effect of selenium (Se), but the reports are inconsistent. The objective of the study was to examine the evidence for relation between serum/tissue Se status and CRC.
METHOD AND MATERIALS: In this Systematic Review and Meta-Analysis, we searched Cochrane Library, EBSCOhost, EMBASE, ProQuest, PubMed/MEDLINE, Scopus, and Web of Science for studies reporting serum/plasma/whole blood/tissue Se concentrations in CRC patients and controls for articles published till August 2023. Meta-analysis was performed, and study quality, heterogeneity, and small study effects were assessed. Based on a random effects model, summary mean differences in serum levels of Se between CRC patients and healthy controls, and Se levels between malignant and matched non-malignant tissue specimens were assessed.
RESULTS: After initial screening, a total of 24 studies (18 serum and 6 tissue studies) with a pooled total of 2640 participants were included in the meta-analysis. CRC patients had significantly lower serum Se levels than healthy controls, being the difference between the two equal to 3.73 µg/dl (95% CI: 6.85-0.61). However, the heterogeneity was very high, I2= 99% (p < 0.01). Our meta-analysis showed higher Se levels in CRC cancerous specimens than in matched healthy colon tissue: the increase was equal to 0.07 µg/g wet tissue weight (95% CI: 0.06-0.09; p= 0.02).
CONCLUSIONS: CRC patients have lower serum and higher colon cancerous tissue Se levels. Some factors, such as Se levels in different tumor grades of CRC need to be further considered for a more conclusive association between Se levels and risk of CRC.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
---|---|
Enthalten in: |
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) - 84(2024) vom: 12. März, Seite 127429 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pal, Amit [VerfasserIn] |
---|
Links: |
---|
Themen: |
Colorectal cancer |
---|
Anmerkungen: |
Date Revised 17.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.jtemb.2024.127429 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369833503 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369833503 | ||
003 | DE-627 | ||
005 | 20240318235038.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240318s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jtemb.2024.127429 |2 doi | |
028 | 5 | 2 | |a pubmed24n1335.xml |
035 | |a (DE-627)NLM369833503 | ||
035 | |a (NLM)38493666 | ||
035 | |a (PII)S0946-672X(24)00049-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pal, Amit |e verfasserin |4 aut | |
245 | 1 | 0 | |a Selenium levels in colorectal cancer |b A systematic review and meta-analysis of serum, plasma, and colorectal specimens |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 17.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024 Elsevier GmbH. All rights reserved. | ||
520 | |a BACKGROUND: Colorectal cancer (CRC) is a growing public health problem. Several clinical studies have shown a potentially protective effect of selenium (Se), but the reports are inconsistent. The objective of the study was to examine the evidence for relation between serum/tissue Se status and CRC | ||
520 | |a METHOD AND MATERIALS: In this Systematic Review and Meta-Analysis, we searched Cochrane Library, EBSCOhost, EMBASE, ProQuest, PubMed/MEDLINE, Scopus, and Web of Science for studies reporting serum/plasma/whole blood/tissue Se concentrations in CRC patients and controls for articles published till August 2023. Meta-analysis was performed, and study quality, heterogeneity, and small study effects were assessed. Based on a random effects model, summary mean differences in serum levels of Se between CRC patients and healthy controls, and Se levels between malignant and matched non-malignant tissue specimens were assessed | ||
520 | |a RESULTS: After initial screening, a total of 24 studies (18 serum and 6 tissue studies) with a pooled total of 2640 participants were included in the meta-analysis. CRC patients had significantly lower serum Se levels than healthy controls, being the difference between the two equal to 3.73 µg/dl (95% CI: 6.85-0.61). However, the heterogeneity was very high, I2= 99% (p < 0.01). Our meta-analysis showed higher Se levels in CRC cancerous specimens than in matched healthy colon tissue: the increase was equal to 0.07 µg/g wet tissue weight (95% CI: 0.06-0.09; p= 0.02) | ||
520 | |a CONCLUSIONS: CRC patients have lower serum and higher colon cancerous tissue Se levels. Some factors, such as Se levels in different tumor grades of CRC need to be further considered for a more conclusive association between Se levels and risk of CRC | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Colorectal cancer | |
650 | 4 | |a Selenium | |
650 | 4 | |a Systematic Reviews and Meta-analysis | |
700 | 1 | |a Dhar, Aninda |e verfasserin |4 aut | |
700 | 1 | |a Shamim, Muhammad Aaqib |e verfasserin |4 aut | |
700 | 1 | |a Rani, Isha |e verfasserin |4 aut | |
700 | 1 | |a Negi, Ram Rattan |e verfasserin |4 aut | |
700 | 1 | |a Sharma, Aaina |e verfasserin |4 aut | |
700 | 1 | |a Chatterjee, Namrata |e verfasserin |4 aut | |
700 | 1 | |a Goyal, Anmol |e verfasserin |4 aut | |
700 | 1 | |a Sadashiv |e verfasserin |4 aut | |
700 | 1 | |a Kaur, Bandhan |e verfasserin |4 aut | |
700 | 1 | |a Tondolo, Vincenzo |e verfasserin |4 aut | |
700 | 1 | |a Rongioletti, Mauro |e verfasserin |4 aut | |
700 | 1 | |a Samantaray, Subha Ranjan |e verfasserin |4 aut | |
700 | 1 | |a Hoque, Mehboob |e verfasserin |4 aut | |
700 | 1 | |a Pawar, Anil |e verfasserin |4 aut | |
700 | 1 | |a Goswami, Kalyan |e verfasserin |4 aut | |
700 | 1 | |a Squitti, Rosanna |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) |d 1997 |g 84(2024) vom: 12. März, Seite 127429 |w (DE-627)NLM085797529 |x 1878-3252 |7 nnns |
773 | 1 | 8 | |g volume:84 |g year:2024 |g day:12 |g month:03 |g pages:127429 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jtemb.2024.127429 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 84 |j 2024 |b 12 |c 03 |h 127429 |